Clinical Characteristics and Outcomes of Patients With ANCA-Associated Vasculitides in a Colombian Hospital

被引:2
|
作者
Santacruz-Sandoval, Evelyn [1 ]
Lopez-Bonilla, Jorge [1 ]
Guevara-Calderon, Lizbeth A. [1 ]
Nieto-Aristizabal, Ivana [2 ]
Ruiz-Ordonez, Ingrid [2 ]
Canas, Carlos A. [3 ,4 ]
Santos, Victor A. [5 ]
Tobon, Gabriel J. [3 ,4 ]
Aguirre-Valencia, David [3 ,4 ]
机构
[1] Univ Icesi, Med Sch, Cali, Colombia
[2] Fdn Valle Lili, Ctr Invest Clin, Cali, Colombia
[3] Univ Icesi, Ctr Invest Reumatol Autoinmunidad & Med Traslac, Cra 98 18-49, Cali 760032, Colombia
[4] Fdn Valle Lili, Unit Rheumatol, Cali, Colombia
[5] Univ Icesi, Med Sch, Dept Internal Med, Unit Rheumatol, Cali, Colombia
关键词
ANCA-associated vasculitides; granulomatosis with polyangiitis; microscopic polyangiitis; eosinophilic granulomatosis with polyangiitis; intensive care unit; epidemiology; ANTIBODY-ASSOCIATED VASCULITIS; CYCLOPHOSPHAMIDE; RITUXIMAB; INDUCTION; DISEASE;
D O I
10.1097/RHU.0000000000001775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objective Antineutrophil cytoplasmic antibody-associated vasculitides (AAVs) are uncommon systemic autoimmune diseases, of which few reports exist in Latin America. Our aim was to examine AAV evaluated in a high-complexity hospital in southwestern Colombia, with emphasis in severe forms. Methods A medical records review study of 67 patients was performed, and data were collected from electronic registries. Moderate and severe AAVs were defined as the presence of life-threatening complications, unfavorable Birmingham Vasculitis Activity Score outcomes, and hospitalization requirements at the time of diagnosis and by the last follow-up, between 2011 and 2019. Clinical manifestations, treatment, and outcomes were evaluated. The AAV subtypes were compared. Results A total of 67 cases were included. The majority were female (n = 44, 65.67%), and the median age was 52 (40-64) years. Granulomatosis with polyangiitis (GPA) was the most frequent with 42 patients (62.68%), followed by microscopic polyangiitis (MPA) and eosinophilic GPA, with 15 patients (22.38%) and 10 patients (14.92%), respectively. Forty-four patients (65.67%) presented pulmonary symptoms. The highest Birmingham Vasculitis Activity Score corresponded to MPA, with 21 (12-25) points. Fifteen patients (22.4%) were admitted to the intensive care unit throughout the course of the disease, of whom 10 had GPA. The longest stay and duration of mechanical ventilation were seen in MPA. The principal treatments were corticosteroids and cyclophosphamide, and the main outcome was end-stage renal disease. Conclusions In this cohort of AAV, most of cases corresponded to GPA, and pulmonary manifestations were the most common. Microscopic polyangiitis was the more severe subtype as it showed worse impairment in clinical characteristics and intensive care unit requirements.
引用
收藏
页码:E491 / E497
页数:7
相关论文
共 50 条
  • [1] ANCA-Associated Vasculitides
    Stegert, Mihaela
    Neumann, Thomas
    Daikeler, Thomas
    THERAPEUTISCHE UMSCHAU, 2022, 79 (05) : 229 - 237
  • [2] Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA-associated vasculitides
    Wojcik, Krzysztof
    Masiak, Anna
    Jeleniewicz, Radoslaw
    Jakuszko, Katarzyna
    Brzosko, Iwona
    Storoniak, Hanna
    Kur-Zalewska, Joanna
    Wislowska, Malgorzata
    Madej, Marta
    Hawrot-Kawecka, Anna
    Gluszko, Piotr
    Kucharz, Eugeniusz J.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2022, 132 (03):
  • [3] Clinical characteristics of Polish patients with ANCA-associated vasculitides—retrospective analysis of POLVAS registry
    K. Wójcik
    K. Wawrzycka-Adamczyk
    A. Włudarczyk
    J. Sznajd
    Z. Zdrojewski
    A. Masiak
    Z. Czuszyńska
    M. Majdan
    R. Jeleniewicz
    M. Klinger
    K. Jakuszko
    O. Rowaiye
    M. Brzosko
    M. Milchert
    A. Dębska-Ślizień
    H. Storoniak
    W. Tłustochowicz
    J. Kur-Zalewska
    M. Wisłowska
    M. Madej
    A. Hawrot-Kawecka
    P. Głuszko
    E. Kucharz
    Jacek Musiał
    Clinical Rheumatology, 2019, 38 : 2553 - 2563
  • [4] Thromboembolic complications in patients with ANCA-associated vasculitides
    Wrenger, E
    Moesenthin, MM
    Bartsch, P
    Neumann, KH
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V233 - V233
  • [5] SECONDARY CRYOFIBRINOGENAEMIA IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIDES
    Shevtsova, Tatyana
    Moiseev, Sergey
    Smitienko, Ilya
    Novikov, Pavel
    RHEUMATOLOGY, 2017, 56 : 148 - +
  • [6] Rituximab for ANCA-associated vasculitides
    Guillevin, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S118 - S121
  • [7] Genetics of ANCA-associated Vasculitides
    Ugarte-Gil, Manuel F.
    Espinoza, Luis R.
    CURRENT RHEUMATOLOGY REPORTS, 2014, 16 (07)
  • [8] ANCA-associated vasculitides in childhood
    Diána Garan
    Zsófia Bence
    Zsófia Gács
    András Szabó
    Tamás Constantin
    Pediatric Rheumatology, 9 (Suppl 1)
  • [9] Are ANCA-associated vasculitides inherited?
    Hellmich, B
    Epplen, JT
    Gross, WL
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (06) : S1 - S2
  • [10] Atherosclerosis in ANCA-Associated vasculitides
    Pagnoux, Christian
    Chironi, Gilles
    Simon, Alain
    Guillevin, Loic
    AUTOIMMUNITY, PT C: THE MOSAIC OF AUTOIMMUNITY, 2007, 1107 : 11 - 21